Letters to HCPs

BLINCYTO®▼ (blinatumomab) – Clarification of timing of premedication with dexamethasone in paediatric patients

A potentially confusing statement which led to a translation issue has been discovered in the Blincyto® Summary of Product Characteristic (SmPC) Section 4.2 regarding the second administration of dexamethasone as premedication in paediatric patients

For Healthcare Professionals